Heterogeneity Test Results for Glomerulonephritis eQTL Analysis
by Guoqiang Li·Updated 2mo ago
1.6 MB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
1.6 MB of Excel data containing results from a multi-omics Mendelian randomization analysis of glomerulonephritis subtypes. The dataset, authored by Guoqiang Li and last updated in April 2026, includes proteomic and transcriptomic quantitative trait loci (pQTL/eQTL) applied to GWAS for acute, chronic, IgA nephropathy, and membranous nephropathy. Bayesian colocalization, replication in the FinnGen cohort, and translational annotations were used to identify potential therapeutic targets.
Use Cases
Validate causal gene targets for glomerulonephritis subtypes based on Mendelian randomization results.
Prioritize drug repurposing candidates based on translational annotations linking genes like IL6R and MBL2 to immune pathways.
Compare genetic architecture across GN subtypes using the identified candidate genes (e.g., RECQL for acute GN, HCK for membranous nephropathy).
Assess the strength of causal inference using the Bayesian colocalization results (PPH4 > 0.8) for genes like HCK and CD302.
Strengths
Includes results from systematic multi-omics analysis integrating proteomic and transcriptomic QTLs.
Provides replication and meta-analysis using the independent FinnGen cohort.
Contains downstream translational annotations evaluating mouse knockout phenotypes and drug repositioning.
Limitations
Column-level documentation is absent; field semantics must be inferred after download.
Row count is unknown, which may limit suitability assessment.
Data may reflect methodological bias inherent to the specific Mendelian randomization and colocalization approaches used.
Provenance
Source
figshare
Collection Method
Results from a systematic multi-omics Mendelian randomization analysis.
Freshness
Last updated 2026-04-16 17:46:19; freshness should be verified.
Data is provided in XLSX format; requires Excel or compatible spreadsheet software.